Work

Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2014

Authors: R. Lai, L. D. Recht, D. A. Reardon, N. Paleologos, M. D. Groves, M. R. Rosenfeld, S. Meech, T. A. Davis, D. Pavlov, J. H. Sampson

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242075763

Cites:

Cited by: 10

Related to: 10